Endometrial Ablation Devices– General Surgery Market Analysis and Forecast Model

Endometrial Ablation Devices are used for treatment of Abnormal Menstrual Bleeding (Mennorhagia). Endometrial ablation Device is used for the removal of a portion of endometrial layer of the uterus and the endometrial layer is still functional but significant reduction in menstrual blood is observed. The procedure involved is Hysterectomy surgery for 1st generation technique whereas for 2nd generation techniques hysteroscope is not required. Endometrial Ablation is generally performed in premenopausal women with high menstrual bleeding (HMB) and those who have completed child bearing and women with normal uterine or having small uterine fibroids of size less than 3 cm in diameter. In women with HMB alone and pregnancy of 10 months endometrial ablation is preferred by the use of hysteroscope. There are varying modalities in which endometrial ablation can be performed including surgical energy (RF, Microwave, Cryoablation) or standalone techniques such as thermal balloon ablation.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the Endometrial Ablation Devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Key Highlights

Competitive Assessment

Currently marketed Endometrial Ablation Devices and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total Endometrial Ablation Devices market revenue by segment and market outlooks from 2015–2028.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Reasons to buy

The model will enable you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Endometrial Ablation Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Endometrial Ablation Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Endometrial Ablation Devices market from 2015-2028.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Companies mentioned

  • Boston Scientific Corp
  • Johnson & Johnson
  • Medtronic Plc
  • Olympus Corp
  • CooperSurgical Inc
  • Minerva Surgical Inc
  • Hologic Inc
  • Veldana
  • Omnitech Systems Inc
  • AngioDynamics Inc
  • Boston Scientific Corp
  • Johnson & Johnson
  • Medtronic Plc
  • Olympus Corp
  • CooperSurgical Inc
  • Minerva Surgical Inc
  • Hologic Inc
  • Veldana
  • Omnitech Systems Inc
  • AngioDynamics Inc

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports